| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.1M | -13.0% |
| Gross Profit | $3.5M | +3.4% |
| R&D Expense | $404K | +100.0% |
| SG&A Expense | $8.8M | +111.3% |
| Operating Income | -$5.8M | — |
| Pre-tax Income | -$5.3M | -437.3% |
| Income Tax | $1K | +0.0% |
| Net Income | -$5.3M | — |
| EPS (Basic) | -$0.11 | -1000.0% |
| EPS (Diluted) | -$0.11 | -1000.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $439K | -56.1% |
| Current Assets | $28.8M | — |
| Total Assets | $29.6M | — |
| Current Liabilities | $2.3M | +1361.7% |
| Total Liabilities | $2.4M | +1465.6% |
| Stockholders' Equity | $27.2M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -8935.7% |
| Capital Expenditures | $105K | — |
| Investing Cash Flow | -$98K | — |
| Financing Cash Flow | $29.2M | — |
| Free Cash Flow | -$4.0M | -9177.1% |